| Literature DB >> 25361798 |
Louis Burt Nabors1, Jana Portnow1, Mario Ammirati1, Henry Brem1, Paul Brown1, Nicholas Butowski1, Marc C Chamberlain1, Lisa M DeAngelis1, Robert A Fenstermaker1, Allan Friedman1, Mark R Gilbert1, Jona Hattangadi-Gluth1, Deneen Hesser1, Matthias Holdhoff1, Larry Junck1, Ronald Lawson1, Jay S Loeffler1, Paul L Moots1, Maciej M Mrugala1, Herbert B Newton1, Jeffrey J Raizer1, Lawrence Recht1, Nicole Shonka1, Dennis C Shrieve1, Allen K Sills1, Lode J Swinnen1, David Tran1, Nam Tran1, Frank D Vrionis1, Patrick Yung Wen1, Nicole R McMillian1, Maria Ho1.
Abstract
The NCCN Guidelines for Central Nervous System Cancers provide multidisciplinary recommendations for the clinical management of patients with cancers of the central nervous system. These NCCN Guidelines Insights highlight recent updates regarding the management of metastatic brain tumors using radiation therapy. Use of stereotactic radiosurgery (SRS) is no longer limited to patients with 3 or fewer lesions, because data suggest that total disease burden, rather than number of lesions, is predictive of survival benefits associated with the technique. SRS is increasingly becoming an integral part of management of patients with controlled, low-volume brain metastases.Entities:
Mesh：
Year: 2014 PMID： 25361798 PMCID： PMC4337873 DOI： 10.6004/jnccn.2014.0151
Source DB: PubMed Journal: J Natl Compr Canc Netw ISSN： 1540-1405 Impact factor: 11.908